Sophia Genetics Sa · NASDAQ:SOPH
Sophia Genetics Sa — Fact Sheet (October 2024)
2 slides from Sophia Genetics Sa's fact sheet, October 2024
Slide 1: SOPHiA DDM Myeloid Plus Solution
SOPHiA DDM™ Myeloid Plus Solution The genomic application that streamlines the interpretation of complex variants by combining the DNA target capture and RNA target enrichment kits with the analytical performance and advanced features of the SOPHiA DDM ™ Platform. Main Features Analytical Performanc
Slide 2: RNA Gene Fusion Panel
RNA Gene Fusion Panel ATF7IP(13)-JAK2(9,11,13,15,17,18,19), BCR(1,4,6,7,12,13,14,19)-ABL1(2,3,4), BCR(1,4,6,7,12,13,14,19)-FGFR1(11), BCR(1,4,6,7,12,13,14,19)-JAK2(9,11,13,15,17,18,19), BCR(1,4,6,7,12,13,14,19)-PDGFRA(12), BMP2K(14,15)-ZNF384(2,3,4,7), CBFA2T3(10,11)-GLIS2(4,5), CBFB(4,5)-MYH11(29,3